Skip to Main Content
Legislation Search

H.R. 2002: Patient Matching And Transparency in Certified Health IT Act of 2025

This bill, known as the Patient Matching And Transparency in Certified Health IT Act of 2025, aims to improve the systems for accurately matching patients with their medical records in the healthcare system. Here are the key components and provisions of the bill:

Objectives and Findings

The bill starts with findings that highlight the significance of precise patient identification. The current healthcare system lacks:

  • A national strategy for accurate patient matching.
  • A standardized definition of "patient match rate".
  • Effective management of issues such as duplicate and overlaid medical records, which can result in severe patient safety risks and unnecessary healthcare costs.

It is noted that patient misidentification can lead to medical errors, repeated unnecessary medical tests, and significant financial losses for hospitals and the healthcare system, amounting to billions annually.

Establishment of Standards

The bill directs the Secretary of Health and Human Services to develop a uniform definition and standards for patient match rates within 180 days of enactment. This includes:

  • Addressing issues of duplicate and overlaid records.
  • Tracking the accuracy of patient matches within healthcare providers and systems.

The Secretary is also mandated to review and update these standards regularly, at least every three years.

Data Set Development

Within 180 days of the enactment, the National Coordinator of Health Information Technology is required to:

  • Review and identify a minimum data set essential for supporting patient matching that achieves a 99.9 percent match rate.
  • Incorporate this minimum data set into established interoperability standards for electronic health records (EHR).

This data set will be developed with input from healthcare providers, EHR vendors, patient groups, and other stakeholders.

Integration in Certification Requirements

The bill also mandates the incorporation of the established minimum data set into the certification criteria for health information technology by the Secretary within 180 days of finalization. Moreover, two years after this incorporation, the minimum data set will be required for Medicare interoperability program criteria.

Incentives for Interoperability

To encourage accurate patient matching, the bill requires the Centers for Medicare and Medicaid Services to establish a voluntary bonus incentive for providers who achieve a specified patient match rate, initially set at 90 percent. This will include:

  • A voluntary reporting program for providers to submit patient matching accuracy data anonymously.
  • Annual evaluations of patient match rates, where adjustments can be made to the criteria based on reported data.

Importantly, participants will not be penalized in their scores for not reporting a patient match rate, and the specifics of such reports will remain confidential.

Overall Goal

The overarching aim of this legislation is to enhance the interoperability of health records, thereby reducing patient misidentification, improving patient safety, and decreasing unnecessary healthcare costs driven by misidentifications.

Relevant Companies

  • AMGN (Amgen Inc.): As a major player in healthcare, they may need to adapt their record-keeping and patient management protocols to align with the new standards.
  • CERN (Cerner Corporation): As an EHR vendor, Cerner will be directly impacted by the requirements to adopt the improved minimum data set and patient matching standards.
  • EPD (Entergy Corporation): They may face implications related to managing healthcare data systems that need to comply with the new regulations set forth in the bill.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

11 bill sponsors

Actions

2 actions

Date Action
Mar. 10, 2025 Introduced in House
Mar. 10, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Cliff Bentz R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 09, 2025 Jun 06, 2025 -1.52%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 19, 2025 May 14, 2025 +7.39%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $15,001 - $50,000
Jun 22, 2025 May 12, 2025 +1.42%
Congress pfp
Marjorie Taylor Greene R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 06, 2025 May 05, 2025 -4.31%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -13.22%
Congress pfp
Jared Moskowitz D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 09, 2025 Apr 16, 2025 -13.22%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc
Sale (Full) $15,001 - $50,000
May 15, 2025 Apr 15, 2025 -15.12%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
May 08, 2025 Apr 11, 2025 -12.68%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 09, 2025 -12.51%
Congress pfp
Robert Bresnahan R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
May 08, 2025 Apr 08, 2025 -19.18%
Congress pfp
Jefferson Shreve R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $15,001 - $50,000
Mar 09, 2025 Feb 24, 2025 -8.21%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 19, 2025 -0.49%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 22, 2025 +6.09%
Congress pfp
Emily Randall D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 +10.45%
Congress pfp
Virginia Foxx R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jan 06, 2025 Dec 06, 2024 +6.65%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 15, 2024 -1.44%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Dec 05, 2024 Nov 12, 2024 -4.79%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 14, 2024 -14.95%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Nov 08, 2024 Oct 11, 2024 -16.86%
Congress pfp
Sheldon Whitehouse D / Senate
AMGN logo
AMGN Amgen Inc
Sale (Partial) $1,001 - $15,000
Oct 10, 2024 Sep 17, 2024 -21.20%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Oct 04, 2024 Sep 09, 2024 -22.69%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $50,001 - $100,000
Aug 20, 2024 Aug 07, 2024 -24.90%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN C�������: OUR BROKER PURCHASED SHARES OF 29 STOCKS IN MY SPOUSE'S ROTH IRA ON 8/7/24 IN ORDER TO REBALANCE THE PORTFOLIO IN ACCORDANCE WITH THE FIRM'S INVESTMENT STRATEGY FOR ACCOUNTS THAT SIZE. HE FAILED TO NOTIFY ME OF THESE TRANSACTIONS AND IT WASN'T DISCOVERED UNTIL I WAS ATTEMPTING TO RECONCILE OUR INVESTMENT HOLDINGS FOR MY 2024 FINANCIAL DISCLOSURE. SP AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Jul 03, 2025 Aug 07, 2024 -24.90%
Congress pfp
Scott Franklin R / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2024 Aug 02, 2024 -27.75%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -27.75%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Sep 06, 2024 Aug 02, 2024 -27.75%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -17.73%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -17.73%
Congress pfp
Ro Khanna D / House
AMGN logo
AMGN AMGEN INC. CMN
Sale $15,001 - $50,000
Jun 05, 2024 May 29, 2024 -17.97%
Congress pfp
Kathy E. Manning D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Feb 06, 2024 Jan 23, 2024 -32.44%
Congress pfp
Tommy Tuberville R / Senate
AMGN logo
AMGN Amgen Inc. - Common Stock
Sale (Full) $15,001 - $50,000
Feb 14, 2024 Jan 19, 2024 -32.46%
Congress pfp
Michael C. Burgess R / House
AMGN logo
AMGN AMGEN INC.
Sale $15,001 - $50,000
Jan 22, 2024 Jan 02, 2024 -31.84%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Sale $1,001 - $15,000
Nov 09, 2023 Oct 24, 2023 -39.31%
Congress pfp
Greg Stanton D / House
AMGN logo
AMGN AMGEN INC.
Purchase $1,001 - $15,000
Nov 09, 2023 Sep 26, 2023 -35.15%